IXHLIncannex Healthcare Ltd

Nasdaq www.incannex.com


$ 1.72 $ 0.11 (6.75 %)    

Monday, 16-Sep-2024 15:59:16 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 1.74
$ 1.71
$ 1.66 x 100
-- x --
$ 1.69 - $ 1.72
$ 1.50 - $ 12.68
16,647
na
27.62M
$ 1.10
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 incannex-secures-60m-financing-to-drive-advances-in-psychedelic-and-cannabinoid-therapies

Incannex Healthcare secures $60M in financing from Arena Investors to support clinical trials for cannabinoid and psychedelic t...

 fda-clears-incannex-to-proceed-with-phase-2-psilocybin-assisted-therapy-trial-for-anxiety

FDA approves Incannex's Phase 2 trial for psilocybin-assisted psychotherapy in treating generalized anxiety disorder, follo...

 incannex-to-launch-fda-approved-psilocybin-trial-for-anxiety-disorder-in-us-and-uk

Incannex Healthcare Inc. (NASDAQ:IXHL), (‘Incannex' or the ‘Company'), a clinical-stage pharmaceutical company developi...

 incannex-healthcare-files-for-offering-of-4m-common-shares-along-with-warrants-to-purchase-up-to-4m-common-shares

- SEC Filing

 fda-experts-weigh-in-on-incannexs-cannquit-o-with-feedback-on-cbd-as-treatment-for-opioid-use-disorder

Incannex Healthcare Inc., a cannabinoid and psychedelic medicine biotechnology company, announced the successful completion of ...

 psychedelic-assisted-therapy-advancements-create-a-new-horizon-for-mental-health-in-colorado

Psilocybin-assisted therapy shows promise in treating GAD. Denver trains first responders in psychedelic crisis intervention. H...

Core News & Articles

https://www.marijuanamoment.net/indiana-lawmakers-send-psilocybin-research-funding-bill-to-governor/   The Indiana legislatur...

 incannex-healthcare-tapped-treasurer-and-controller-joseph-swan-to-additional-role-of-cfo-effective-february-29-after-madhukar-bhalla-decided-to-retire

Madhukar Bhalla, Chief Financial Officer and Secretary of Incannex Healthcare Inc. (the “Company”), recently notified the Compa...

 why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

 whats-going-on-with-incannex-stock

Incannex said that its Phase 2 Psi-GAD1 clinical trial of psilocybin in generalized anxiety disorder met its primary endpoint o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION